The partnership will connect Evogene’s AI-based ChemPass AI with the BCDD’s laboratory infrastructure.

Computational drug design for SARS-CoV-2 inhibition has emerged as a keystone in the rapid discovery of antiviral leads, drawing on advances in structural biology, cheminformatics and artificial ...

Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational chemistry company focused on the generative design of small molecules for the pharmaceutical and agricultural industries, and the ...

Hitting targets embedded within the cell membrane has long been difficult for drug developers due to the membrane's challenging biochemical properties. Now, chemists have demonstrated new ...

Drug discovery is the process of identifying and designing new chemical entities that can safely and effectively treat ...

SHANGHAI & BOSTON--(BUSINESS WIRE)--Perpetual Medicines today announced it has closed an $8 million seed financing to advance its integrated computational design and synthesis platform for peptide ...

The Icahn School of Medicine at Mount Sinai launched the AI Small Molecule Drug Discovery Center which was created to integrate AI with traditional drug discovery methods to identify and design new ...

Researchers are left with the challenge of predicting how strongly a potential drug molecule will bind to its target, so there is a high demand for computational approaches that can design compounds ...

In early-phase drug discovery, we do a good job of tracking the obvious productivity metrics, like compound attrition rates, hit-to-lead timelines, and computational resource spend. Other costs are ...